Log in to save to my catalogue

RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovar...

RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovar...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d1d685a0f6e94ed4ad24a9147d62ada6

RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer

About this item

Full title

RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer

Publisher

Ann Arbor: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2022-11, Vol.132 (22), p.1-16

Language

English

Formats

Publication information

Publisher

Ann Arbor: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Prevalent copy number alteration is the most prominent genetic characteristic associated with ovarian cancer (OV) development, but its role in immune evasion has not been fully elucidated. In this study, we identified RAD21, a key component of the cohesin complex, as a frequently amplified oncogene that could modulate immune response in OV. Through...

Alternative Titles

Full title

RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d1d685a0f6e94ed4ad24a9147d62ada6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d1d685a0f6e94ed4ad24a9147d62ada6

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI159628

How to access this item